A new research study shows how cannabigerol, the common cannabinoid known as CBG, killed a variety of strains of MRSA, the antibiotic-resistant staph bacteria. The researchers went further than previous studies by moving beyond the petri dish and testing CBD on rodents. Their results could be the first step in making CBG the newest antibiotic on […]
According to a new study, cannabinoids CBC (cannabichromene) and CBG (cannabigerol) both exhibit anti-tumor properties, tested on human gastrointestinal cancer cells. CBC and CBG were both shown to induce significantly higher rates of necrosis in GI cancer cells compared to other cannabinoids, thus strengthening previously obtained results. See the original article on Cannabis Business Times